Загрузка...
The use of Matrigel combined with encapsulated cell technology to deliver a complement inhibitor in a mouse model of choroidal neovascularization
PURPOSE: Risk for age-related macular degeneration (AMD), a slowly progressing, complex disease, is tied to an overactive complement system. Efforts are under way to develop an anticomplement-based treatment to be delivered locally or systemically. We developed an alternative pathway (AP) inhibitor...
Сохранить в:
| Опубликовано в: : | Mol Vis |
|---|---|
| Главные авторы: | , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Molecular Vision
2020
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7245607/ https://ncbi.nlm.nih.gov/pubmed/32476817 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|